Zusammenfassung
Durch organerhaltende Resektion (subtotale Adrenalektomie) oder adrenokortikale Autotransplantation kann bei bilateraler Nebennierenchirurgie die adrenokortikale Stresskompetenz erhalten werden. Bei der adrenokortikalen Autotransplantation beträgt die Erfolgsrate ca. 30%, bei der organerhaltenden Resektion dagegen mindestens 80%. Bei organerhaltenden Resektionen bei sekundären oder familiären Erkrankungen ist jedoch das Risiko der Rezidiventwicklung zu berücksichtigen: Bei familiären Phäochromozytomen muss innerhalb von 20 Jahren mit einer Rezidivrate von bis zu 20% gerechnet werden. Nach subtotaler Adrenalektomie sollte auf die routinemäßige Gabe von Kortison verzichtet werden, da dadurch die Restitution des Restgewebes gehemmt werden kann. Allerdings muss beachtet werden, dass ca. 80% dieser Patienten zunächst eine eingeschränkte adrenokortikale Stresskompetenz aufweisen. Im Laufe weniger Wochen kommt es jedoch bei bis zu 80% der Patienten zu einer ausreichenden Erholung der Stressfunktion. Organerhaltende Nebennierenoperationen sollten endoskopisch erfolgen. Der Organrest sollte möglichst nicht devaskularisiert werden, die Nebennierenvene kann allerdings problemlos durchtrennt werden. Ein Drittel einer normalen Nebenniere ist in den meisten Fällen für eine suffiziente Nebennierenrindenfunktion ausreichend.
Abstract
Organ preserving resection (subtotal adrenalectomy) or adrenocortical autotransplantation can preserve adrenocortical stress capacity in bilateral adrenal surgery. After adrenocortical autotransplantation approximately 30% of patients do not need exogenous steroids. Organ preserving surgery avoids steroid supplementation in more than 80% of cases. After organ preserving resections in secondary or familial diseases, however, there is a relevant risk of recurrent disease: the rate of ipsilateral recurrence in familial pheochromocytoma is approximately 20% during a follow-up of 20 years. Routine administration of exogenous steroids should be avoided after subtotal adrenalectomy as functional restitution of the residual tissue might be disturbed. Approximately 80% of patients, however, present with impaired adrenocortical stress capacity directly after surgery. Within a few weeks some 80% of patients show a sufficient functional restitution of the adrenocortical stress capacity. Organ preserving adrenal surgery should be performed endoscopically. The adrenal remnant should not be devascularized; the adrenal vein, however, can be divided without functional consequences. About one third of a normal adrenal gland usually provides sufficient adrenocortical function.
Literatur
Alesina PF, Hommeltenberg S, Meier B et al (2010) Posterior retroperitoneoscopic adrenalectomy for clinical and subclinical Cushing’s syndrome. World J Surg 34:1391–1397
Alesina PF, Hinrichs J, Meier B et al (2012) Minimally invasive cortical-sparing surgery for bilateral pheochromocytomas. Langenbecks Arch Surg 397:233–238
Bicknell AB, Lomthaisong K, Woods RJ et al (2001) Characterization of a serine protease that cleaves pro-gamma-melanotropin at the adrenal to stimulate growth. Cell 105:903–912
Brauckhoff M, Gimm O, Thanh PN et al (2003) Critical size of residual adrenal tissue and recovery from impaired early postoperative adrenocortical function after subtotal bilateral adrenalectomy. Surgery 134:1020–1027
Brauckhoff M, Stock K, Stock S et al (2008) Limitations of intraoperative adrenal remnant volume measurement in patients undergoing subtotal adrenalectomy. World J Surg 32:863–872
Choi M, Scholl UI, Yue P et al (2011) K + channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension. Science 331:768–72
Decourcy JL (1934) Subtotal bilateral adrenalectomy for hyperadrenalism (essential hypertension). Ann Surg 100:310–318
Engeland WC, Ennen WB, Elayaperumal A et al (2005) Zonespecific cell proliferation during compensatory adrenal growth in rats. Am J Physiol Endocrinol Metab 288:E298–306
Estivariz EF, Lowry PJ, Jackson S (1992) Control of adrenal growth. In: James VHT (Hrsg) The adrenal gland. Raven Press, New York, S 43–70
Fendrich V, Ramaswamy A, Nies C (2003) Hyperaldosteronism persisting after subtotal adrenalectomy. Chirurg 74:473–477
Fu B, Zhang X, Wang GX et al (2011) Long-term results of a prospective, randomized trial comparing retroperitoneoscopic partial versus total adrenalectomy for aldosterone producing adenoma. J Urol 185:1578–1582
Giordano WC (1982) Preservation of adrenocortical function during surgery for bilateral pheochromocytoma. J Urol 127:100–102
Günther G (1972) Mitoses, cell multiplication and cell displacement in the adrenal cortex. Histometric and autoradiographic studies following subtotal and unilateral epinephrectomy. Endokrinologie 60:356–378
Hamberger B, Telenius-Berg M, Cedermark B et al (1987) Subtotal adrenalectomy in multiple en-docrine neoplasia type 2. Henry Ford Hosp Med J 35:127–128
Irvin GL III, Fishman LM, Sher JA (1983) Familial pheochromocytoma. Surgery 94:938–940
Kennedy AL, Montgomery DA, Welbourn RB (1978) Hypothalamic-pituitary-adrenal function of untreated longterm survivors following subtotal adrenalectomy for Cushing’s disease. Ir J Med Sci 147:420–424
Koch CA, Pacak K, Chrousos GP (2002) Genetics of endocrine disease: The molecular pathogenesis of hereditary and sporadic adrenocortical and adrenomedullary tumors. J Clin Endocrinol Metab 87:5367–5384
Kumar A, Hyams ES, Stifelman MD (2009) Robot-assisted partial adrenalectomy for isolated adrenal metastasis. J Endourol 23:651–654
Lacroix A, Ndiaye N, Tremblay J et al (2001) Ectopic and abnormal hormone receptors in adrenal Cushing’s syndrome. Endocr Rev 22:75–110
Machens A, Brauckhoff M, Gimm O et al (2006) Risk-oriented approach to hereditary adrenal pheochromocytoma. Ann N Y Acad Sci 1073:417–428
Neumann HPH, Bender BU, Reincke M et al (1999) Adrenal-sparing surgery for pheochromocytoma. Br J Surg 86:94–97
Oelkers W (1996) Adrenal insufficiency. N Engl J Med 335:1206–1212
Parnaby CN, Galbraith N, O’Dwyer PJ (2010) Importance of the adrenal gland blood supply during laparoscopic subtotal adrenalectomy. J Laparoendosc Adv Surg Tech A 20:311–315
Pautler SE, Choyke PL, Pavlovich CP et al (2002) Intraoperative ultrasound aids in dissection during laparoscopic partial adrenalectomy. J Urol 168:1352–1355
Priestley JT, Sprague RG, Walters W et al (1951) Subtotal adrenalectomy for Cushing’s syndrome: a preliminary report of 29 cases. Ann Surg 134:464–475
Shigematsu K, Nakagaki T, Yamaguchi N et al (2008) Analysis of mRNA expression for steroidogenic enzymes in the remaining adrenal cortices attached to adrenocortical adenomas. Eur J Endocrinol 158:867–878
Shinojima H, Kakizaki H, Usuki T et al (2001) Clinical and endocrinological features of adrenocorticotropic hormone-independent bilateral macronodular adrenocortical hyperplasia. J Urol 166:1639–1642
Srougi M, Gittes RF, Underwood RH (1980) Influence of exogenous glucocorticoids and ACTH on experimental adrenal autografts. Invest Urol 17:265–268
Telenius-Berg M, Ponder MA, Berg B et al (1989) Quality of life after bilateral adrenalectomy in MEN2. Henry Ford Hosp Med J 37:160–163
Ulrich-Lai YM, Marek DJ, Engeland WC (2002) Capsaicin-sensitive adrenal sensory fibers participate in compensatory adrenal growth in rats. Am J Physiol Regul Integr Comp Physiol 283:R877–R884
Heerden JA van, Sizemore GW, Carney JA et al (1984) Surgical management of the adrenal glands in the multiple endocrine neoplasia type II syndrome. World J Surg 8:612–621
Walther MM, Herring J, Choyke PL et al (2000) Laparoscopic partial adrenalectomy in patients with hereditary forms of pheochromocytoma. J Urol 164:14–17
Walz MK, Peitgen K, Neumann HP et al (2002) Endoscopic treatment of solitary, bilateral, multiple, and recurrent pheochromocytomas and paragangliomas. World J Surg 26:1005–1012
Walz MK, Peitgen K, Diesing D et al (2004) Partial versus total adrenalectomy by the posterior retroperitoneoscopic approach: early and long-term results of 325 consecutive procedures in primary adrenal neoplasias. World J Surg 28:1323–1329
Walz MK, Gwosdz R, Levin SL et al (2008) Retroperitoneoscopic adrenalectomy in Conn’s syndrome caused by adrenal adenomas or nodular hyperplasia. World J Surg 32:847–853
Walz MK (2009) Adrenalectomy for preservation of adrenocortical function. Indication and results. Chirurg 80:99–104
Welander J, Söderkvist P, Gimm O (2011) Genetics and clinical characteristics of hereditary pheochromocytomas and paragangliomas. Endocr Relat Cancer 18:R253–276
Welbourn RB (1985) Survival and causes of death after adrenalectomy for Cushing’s disease. Surgery 97:16–20
Yip L, Lee JE, Shapiro SE et al (2004) Surgical management of hereditary pheochromocytoma. J Am Coll Surg 198:525–534
Young HH (1936) A technique for simultaneous exposure and operation on the adrenals. Surg Gynecol Obstet 63:179–188
Interessenkonflikt
Der korrespondierende Autor gibt für sich und seinen Koautor an, dass kein Interessenkonflikt besteht.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Brauckhoff, M., Dralle, H. Funktionserhaltende Adrenalektomie bei Nebennierentumoren. Chirurg 83, 519–527 (2012). https://doi.org/10.1007/s00104-011-2192-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00104-011-2192-7
Schlüsselwörter
- Subtotale Adrenalektomie
- Adrenokortikale Stresskompetenz
- Familiäres Phäochromozytom
- Postoperatives Management
- Ipsilaterales Rezidiv